Resistance to carbapenems in a leading hospital bacterium hit 69% in 2025, as lawyers report a rise in malpractice cases linked to drug-resistant infections
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
